期刊
ADVANCED MATERIALS
卷 34, 期 15, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202110283
关键词
glutathione response; nanomedicine; open shell; positron emission tomography imaging; sonodynamic therapy
类别
资金
- National Natural Science Foundation of China [82102190, 62173223]
- China Postdoctoral Science Foundation [2020M681326]
- Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20191805]
- Foundation of National Facility for Translational Medicine (Shanghai) [TMSK-2021-122]
- University of Wisconsin-Madison
- National Institutes of Health [P30CA014520]
- National Facility for Translational Medicine (Shanghai)
In this study, a new sonosensitizer Cu(II)NS was synthesized to overcome the challenges of sonodynamic therapy (SDT). By including porphyrins, chelated Cu2+, and poly(ethylene glycol) (PEG), Cu(II)NS showed improved therapeutic effects. The overexpressed glutathione in the tumor can reduce Cu2+ to generate Cu(I)NS, leading to enhanced sonosensitivity. Moreover, PEG increased the blood biological half-life and tumor accumulation of Cu(II)NS, further enhancing the effect of SDT.
Deleterious effects to normal tissues and short biological half-life of sonosensitizers limit the applications of sonodynamic therapy (SDT). Herein, a new sonosensitizer (Cu(II)NS) is synthesized that consists of porphyrins, chelated Cu2+, and poly(ethylene glycol) (PEG) to overcome the challenges of SDT. As Cu2+ contains 27 electrons, Cu(II)NS has an unpaired electron (open shell), resulting in a doublet ground state and little sonosensitivity. Overexpressed glutathione in the tumor can reduce Cu2+ to generate Cu(I)NS, leading to a singlet ground state and recuperative sonosensitivity. Additionally, PEG endows Cu(II)NS with increased blood biological half-life and enhanced tumor accumulation, further increasing the effect of SDT. Through regulating the valence state of Cu, cancer SDT with enhanced therapeutic index is achieved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据